ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

New approach might strike at the core of Alzheimer’s disease

Updated on April 28, 2008

Compound could slow amyloid beta production

By finding a way to stick an enzyme-inhibiting molecule to the membrane of a cell, scientists may have devised the framework for an Alzheimer's drug.

Researchers discovered the enzyme beta-secretase in 1999. Identifying it opened up a new line of attack against Alzheimer's because beta-secretase makes a peptide implicated in the disease. Just as detectives sometimes put the squeeze on small-time crooks in hopes of weakening a crime ring, researchers reasoned that inhibiting beta-secretase could neutralize the real Alzheimer's suspect - the peptide known as amyloid beta.

But it hasn't been easy. While scientists have made many beta-secretase inhibitors, the free-floating compounds haven't knocked down amyloid beta production consistently.

A research team in Germany has now synthesized a compound that anchors a beta-secretase inhibitor to the membrane of a cell using a sterol molecule. With nowhere to roam, the inhibitor portion of the compound thwarts beta secretase's activity. When tested in mice, the strategy halved amyloid beta production, the researchers report in the April 25 Science.

The finding represents a preliminary step, cautions study coauthor Kai Simons, a physician and cell biologist at the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden. But the results show that the sterol-coupled enzyme inhibitor stays in a cell, which may be necessary to keep amyloid beta production in check, he says.

"This is a very elegant study. They actually ... targeted specific sites of action in the cell," says Kumar Sambamurti, a microbiologist at the Medical University of South Carolina, in Charleston, who didn't participate in the research. "The very idea is novel and exciting."

While the precise cause of Alzheimer's disease remains unclear, amyloid beta is without question a prime suspect. Amyloid beta forms when beta-secretase cuts up a larger molecule called amyloid precursor protein. Abnormal accumulations of amyloid beta routinely show up in the spaces between brain cells of patients. These clumps seem to jam signals transmitted between neurons and may contribute to the death of these primary brain cells.

In the new study, the researchers found that the sterol-anchored enzyme inhibitor slowed beta-secretase cleaving in lab cultures of human cells.

Next the scientists tested it in fruit fly larvae genetically engineered to produce beta-secretase and amyloid precursor protein, neither of which the flies make normally. Only 1 percent of such larvae typically hatch, suggesting a detrimental effect. But when fed the sterol-anchored beta-secretase inhibitor, up to 9 percent of larvae hatched.

To gauge an effect in mammals, the scientists injected the sterol-anchored enzyme inhibitor directly into the brains of mice that were engineered to make excess beta-secretase. Mice given the enzyme inhibitor made half as much amyloid beta as mice injected with an inert substance.

Such partial suppression might be better than totally squelching amyloid beta production, Simons says, since the peptide in normal concentrations may play a useful role in the brain.

He says the next step will entail finding a method in animals to get the sterol-coupled enzyme inhibitor into the brain without injecting it, possibly through food. That poses problems since the barrier surrounding the brain is notoriously difficult to traverse.

"The blood-brain barrier is the million dollar question," Sambamurti says.

Simons agrees. Theoretically, if an enzyme inhibitor in pill form could reach neurons, it might slow amyloid beta production enough to allow normal metabolic processes to thin out an overabundance of the substance, he says. There are currently no drugs that reverse Alzheimer's disease.

But tests in people are still five to 10 years off, Simons says, and would first require further successes in animal tests.

Meanwhile, the sterol-coupled enzyme inhibitor compound has no name, and the authors haven't divulged what the inhibiting component is. Although no beta-secretase inhibitors have reached human trials, a compound that thwarts a related enzyme is currently being tested in people



    0 of 8192 characters used
    Post Comment

    No comments yet.


    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at:

    Show Details
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the or domains, for performance and efficiency reasons. (Privacy Policy)
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)